9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 72 filers reported holding 9 METERS BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $189,000 | -17.5% | 878,171 | +0.2% | 0.66% | +250.0% |
Q2 2022 | $229,000 | -55.3% | 876,471 | +2.6% | 0.19% | -19.3% |
Q1 2022 | $512,000 | -18.6% | 854,375 | +0.2% | 0.23% | -19.9% |
Q4 2021 | $629,000 | -42.5% | 852,628 | +1.4% | 0.29% | -44.6% |
Q3 2021 | $1,093,000 | – | 840,727 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 3,115,000 | $2,676,000 | 1.09% |
Worth Venture Partners, LLC | 789,341 | $678,000 | 0.54% |
Tri Locum Partners LP | 1,390,821 | $1,195,000 | 0.43% |
Altium Capital Management LP | 1,264,994 | $1,087,000 | 0.41% |
Saltoro Capital, LP | 700,000 | $601,000 | 0.30% |
Orbimed Advisors | 25,716,755 | $22,091,000 | 0.19% |
PERKINS CAPITAL MANAGEMENT INC | 300,000 | $258,000 | 0.17% |
MYDA Advisors LLC | 360,000 | $309,000 | 0.09% |
Maven Securities LTD | 750,000 | $667,000 | 0.07% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 13,000,000 | $11,167,000 | 0.02% |